Guillain-barré syndrome associated with Japanese encephalitis virus infection in China

Viral Immunology

Volumn 27, Issue 8, 2014, Pages 418-420

  Xiang, Jing Yan ^a   Zhang, Yu Hua ^b   Tan, Zhi Rong ^b   Huang, Jie ^b   Zhao, Yu Wu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b Department of Clinical Laboratory Xishuangbanna Jing Hong People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN M ANTIBODY; MEPREDNISONE; ANTIINFLAMMATORY AGENT; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTOR; METHYLPREDNISOLONE; VIRUS ANTIBODY;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CASE REPORT; CHINA; CONVALESCENCE; CORTICOSTEROID THERAPY; COUGHING; DISEASE ASSOCIATION; DYSPNEA; ELECTROMYOGRAPHY; ELISA KIT; FACIAL NERVE PARALYSIS; FEVER; FOLLOW UP; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; HYPOREFLEXIA; IMMUNOTHERAPY; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MALE; NERVOUS SYSTEM ELECTROPHYSIOLOGY; PARESTHESIA; PHYSICAL EXAMINATION; POLYRADICULONEUROPATHY; QUADRIPLEGIA; SENSORY DYSFUNCTION; WEAKNESS; YOUNG ADULT; BLOOD; COMPLICATION; GUILLAIN-BARRE SYNDROME; IMMUNOLOGY; PATHOLOGY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, VIRAL; CHINA; ENCEPHALITIS VIRUSES, JAPANESE; ENCEPHALITIS, JAPANESE; GUILLAIN-BARRE SYNDROME; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; METHYLPREDNISOLONE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907500922     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0049     Document Type: Article

References (11)

1. Asbury AK, and Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27:S21-S24.
2. Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011;89:766-774, 74A-74E.
3. Fischer M, Lindsey N, Staples JE, and Hills S. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010;59:1-27.
4. Guillain-Barré Syndrome Study Group. Guillain-Barré syndrome: an Italian multicentre case-control study. Neurol Sci 2000;21:229-234.
5. Hughes RA, and Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-1666.
6. Hurwitz ES, Holman RC, Nelson DB, and Schonberger LB. National surveillance for Guillain-Barré syndrome: January 1978-March 1979. Neurology 1983;33:150-157.
7. Jacobs BC, Rothbarth PH, van der Meché FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1988;51:1110-1115.
8. Kalita J, and Misra UK. Neurophysiological changes in Japanese encephalitis. Neurol India 2002;50:262-266.
9. Ravi V, Taly AB, Shankar SK, et al. Association of Japanese encephalitis virus infection with Guillain-Barré syndrome in endemic areas of South India. Acta Neurol Scand 1994;90:67-72.
10. Robinson JS, Featherstone D, Vasanthapuram R, et al. Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays. Am J Trop Med Hyg 2010;83:1146-1155.
11. Zheng Y, Li M, Wang H, and Liang G. Japanese encephalitis and Japanese encephalitis virus in mainland China. Rev Med Virol 2012;22:301-322.